Biotech Day In Review: Cell Genesys Climbs On GVAX Results
Seeking Alpha - New York,NY,USA
Opexa (OPXA) said its T-cell vaccine Tovaxin was safe and effective in a Phase I/II trial in patients with multiple sclerosis. ...
See all stories on this topic